In the last trading session, 258.84 million shares of the Mural Oncology plc (NASDAQ:MURA) were traded, and its beta was 5.07. Most recently the company’s share price was $2.41, and it changed around $1.38 or 133.98% from the last close, which brings the market valuation of the company to $41.53M. MURA currently trades at a discount to its 52-week high of $4.74, offering almost -96.68% off that amount. The share price’s 52-week low was $0.95, which indicates that the current value has risen by an impressive 60.58% since then. We note from Mural Oncology plc’s average daily trading volume that its 10-day average is 26.26 million shares, with the 3-month average coming to 271.51K.
Mural Oncology plc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended MURA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Mural Oncology plc is expected to report earnings per share of -2.04 for the current quarter.
Mural Oncology plc (NASDAQ:MURA) trade information
Instantly MURA has showed a green trend with a performance of 133.98% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.2100 on recent trading dayincreased the stock’s daily price by 24.92%. The company’s shares are currently down -25.16% year-to-date, but still up 121.10% over the last five days. On the other hand, Mural Oncology plc (NASDAQ:MURA) is -40.79% down in the 30-day period. We can see from the shorts that 0.59 million shares have been sold at a short interest cover period of 1.48 day(s).
Mural Oncology plc earnings are expected to increase by 28.50% in 2025, but the outlook is positive 31.66% per year for the next five years.
MURA Dividends
Mural Oncology plc’s next quarterly earnings report is expected to be released on 2025-Mar-10.
Mural Oncology plc (NASDAQ:MURA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.62% of Mural Oncology plc shares, and 60.57% of them are in the hands of institutional investors. The stock currently has a share float of 61.57%. Mural Oncology plc stock is held by 96.0 institutions, with ARMISTICE CAPITAL, LLC being the largest institutional investor. By 2024-06-30, it held 9.9735% of the shares, which is about 1.69 million shares worth $5.3 million.
SOLAS CAPITAL MANAGEMENT, LLC, with 7.4979% or 1.27 million shares worth $3.98 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 482.63 shares worth $1.16 million, making up 2.80% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 236.78 shares worth around $0.57 million, which represents about 1.37% of the total shares outstanding.
